[1] |
MYOJIN Y, HIKITA H, SUGIYAMA M, et al. Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production[J]. Gastroenterology, 2021, 160( 5): 1741- 1754. e 16. DOI: 10.1053/j.gastro.2020.12.015.
|
[2] |
MA YN, WANG SS, LIEBE R, et al. Crosstalk between hepatic stellate cells and tumor cells in the development of hepatocellular carcinoma[J]. Chin Med J, 2021, 134( 21): 2544- 2546. DOI: 10.1097/CM9.0000000000001726.
|
[3] |
SUFLEŢEL RT, MELINCOVICI CS, GHEBAN BA, et al. Hepatic stellate cells-from past till present: Morphology, human markers, human cell lines, behavior in normal and liver pathology[J]. Rev Roum De Morphol Embryol, 2020, 61( 3): 615- 642. DOI: 10.47162/RJME.61.3.01.
|
[4] |
LIN N, CHEN ZJ, LU Y, et al. Role of activated hepatic stellate cells in proliferation and metastasis of hepatocellular carcinoma[J]. Hepatol Res, 2015, 45( 3): 326- 336. DOI: 10.1111/hepr.12356.
|
[5] |
GENG ZM, LI QH, LI WZ, et al. Activated human hepatic stellate cells promote growth of human hepatocellular carcinoma in a subcutaneous xenograft nude mouse model[J]. Cell Biochem Biophys, 2014, 70( 1): 337- 347. DOI: 10.1007/s12013-014-9918-3.
|
[6] |
YANG HX, TAN MJ, GAO ZQ, et al. Role of hydrogen sulfide and hypoxia in hepatic angiogenesis of portal hypertension[J]. J Clin Transl Hepatol, 2023, 11( 3): 675- 681. DOI: 10.14218/JCTH.2022.00217.
|
[7] |
LIU Y, XUN ZZ, MA K, et al. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy[J]. J Hepatol, 2023, 78( 4): 770- 782. DOI: 10.1016/j.jhep.2023.01.011.
|
[8] |
SHACKELFORD R, OZLUK E, ISLAM MZ, et al. Hydrogen sulfide and DNA repair[J]. Redox Biol, 2021, 38: 101675. DOI: 10.1016/j.redox.2020.101675.
|
[9] |
ANDRÉS CMC, PÉREZ DE LA LASTRA JM, ANDRÉS JUAN C, et al. Chemistry of hydrogen sulfide-pathological and physiological functions in mammalian cells[J]. Cells, 2023, 12( 23): 2684. DOI: 10.3390/cells12232684.
|
[10] |
WANG SS, CHEN YH, CHEN N, et al. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway[J]. Cell Death Dis, 2017, 8( 3): e2688. DOI: 10.1038/cddis.2017.18.
|
[11] |
ZHANG CH, JIANG ZL, MENG Y, et al. Hydrogen sulfide and its donors: Novel antitumor and antimetastatic agents for liver cancer[J]. Cell Signal, 2023, 106: 110628. DOI: 10.1016/j.cellsig.2023.110628.
|
[12] |
YUAN ZN, ZHENG YQ, WANG BH. Prodrugs of hydrogen sulfide and related sulfur species: Recent development[J]. Chin J Nat Med, 2020, 18( 4): 296- 307. DOI: 10.1016/S1875-5364(20)30037-6.
|
[13] |
YOUNESS RA, HABASHY DA, KHATER N, et al. Role of hydrogen sulfide in oncological and non-oncological disorders and its regulation by non-coding RNAs: A comprehensive review[J]. Noncoding RNA, 2024, 10( 1): 7. DOI: 10.3390/ncrna10010007.
|
[14] |
GAO W, LIU YF, ZHANG YX, et al. The potential role of hydrogen sulfide in cancer cell apoptosis[J]. Cell Death Discov, 2024, 10( 1): 114. DOI: 10.1038/s41420-024-01868-w.
|
[15] |
HAN B, WU LQ, MA X, et al. Synergistic effect of IFN-γ gene on LIGHT-induced apoptosis in HepG2 cells via down regulation of Bcl-2[J]. Artif Cells Blood Substit Immobil Biotechnol, 2011, 39( 4): 228- 238. DOI: 10.3109/10731199.2010.538403.
|
[16] |
ZHENG QY, CAO ZH, HU XB, et al. LIGHT/IFN-γ triggers β cells apoptosis via NF-κB/Bcl2-dependent mitochondrial pathway[J]. J Cell Mol Med, 2016, 20( 10): 1861- 1871. DOI: 10.1111/jcmm.12876.
|
[17] |
ZHANG N, LIU XH, QIN JL, et al. LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment[J]. Mol Ther, 2023, 31( 9): 2575- 2590. DOI: 10.1016/j.ymthe.2023.06.015.
|
[18] |
SKEATE JG, OTSMAA ME, PRINS R, et al. TNFSF14: LIGHTing the way for effective cancer immunotherapy[J]. Front Immunol, 2020, 11: 922. DOI: 10.3389/fimmu.2020.00922.
|
[19] |
SHAULIAN E, KARIN M. AP-1 as a regulator of cell life and death[J]. Nat Cell Biol, 2002, 4( 5): E131- E136. DOI: 10.1038/ncb0502-e131.
|
[20] |
YAN P, ZHOU B, MA YD, et al. Tracking the important role of JUNB in hepatocellular carcinoma by single-cell sequencing analysis[J]. Oncol Lett, 2020, 19( 2): 1478- 1486. DOI: 10.3892/ol.2019.11235.
|
[1] | Zhiyi WANG, Guangyue YANG, Wei ZHANG, Yaqiong PU, Xin ZHAO, Wenting MA, Xuling LIU, Liu WU, Le TAO, Cheng LIU. Role of podoplanin in hepatic stellate cell activation and liver fibrosis[J]. Journal of Clinical Hepatology, 2024, 40(3): 533-538. doi: 10.12449/JCH240316 |
[2] | Jun GAO, Huan CHEN, Yan LIU, Feng ZHANG, Yuzheng ZHUGE. Effect of interleukin-22 on hepatic stellate cell activation and its mechanism[J]. Journal of Clinical Hepatology, 2024, 40(11): 2229-2237. doi: 10.12449/JCH241116 |
[3] | Yuxin YAN, Xiaoyang GAO, Chunyan ZHANG, Rong JIN, Hongwei YUAN, Yuehong MA. Role and mechanism of action of the Mongolian medicine Scabiosa atropurea in inhibiting the proliferation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2023, 39(6): 1351-1357. doi: 10.3969/j.issn.1001-5256.2023.06.015 |
[4] | Jing PENG, Wei YUAN, Sihan YIN, Kewei SUN. Mechanism of NLRP3 inflammasome promoting hepatic stellate cell activation[J]. Journal of Clinical Hepatology, 2022, 38(11): 2611-2615. doi: 10.3969/j.issn.1001-5256.2022.11.035 |
[5] | Ning YANG, Jiang DENG, Yikai WANG, Sha CHANG, Ning GAO, Wenjun WANG, Shuangsuo DANG, Juanjuan SHI. Role and mechanism of caffeic acid phenethyl ester in hepatic stellate cell[J]. Journal of Clinical Hepatology, 2022, 38(10): 2273-2278. doi: 10.3969/j.issn.1001-5256.2022.10.014 |
[6] | Tingyu REN, Hezhongrong NIE, Lijia XIAO, Fangnan LIN, Daming WANG, Chunli SONG, Yiwen ZHOU. Effect of hepatitis B x gene-overexpressed hepatocytes on the proliferation and activation of hepatic stellate cells and related mechanism[J]. Journal of Clinical Hepatology, 2021, 37(7): 1561-1566. doi: 10.3969/j.issn.1001-5256.2021.07.017 |
[7] | Yang MiaoMiao, Wu ZhiHui, Tu ZhengKun. Hepatitis B virus-mediated interaction between hepatic stellate cells and innate immune cells[J]. Journal of Clinical Hepatology, 2020, 36(4): 891-894. doi: 10.3969/j.issn.1001-5256.2020.04.040 |
[8] | Wu Jie, Li JingTao, Wei HaiLiang, Yan ShuGuang, Fan Yu, Guo YingJun, Chang ZhanJie. Advances in the role of microRNA in the intervention of malignant transformation of precancerous lesions of the liver by regulating the activation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2020, 36(7): 1650-1654. doi: 10.3969/j.issn.1001-5256.2020.07.045 |
[9] | Huang XiaoLi, Liu YingYing, Cong Min. Research advances in drug carrier systems targeting hepatic stellate cells[J]. Journal of Clinical Hepatology, 2020, 36(1): 208-212. doi: 10.3969/j.issn.1001-5256.2020.01.050 |
[10] | Li TianYang, Tu ZhengKun, Su LiShan. Regulatory effect of natural killer cells on hepatic stellate cells and their role in liver fibrosis[J]. Journal of Clinical Hepatology, 2017, 33(3): 558-562. doi: 10.3969/j.issn.1001-5256.2017.03.036 |
[11] | Zhao WeiHua, Wang YanHong, Cong Min. Regulatory effect of transforming growth factor-β on activation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(11): 2195-2198. doi: 10.3969/j.issn.1001-5256.2016.11.044 |
[12] | Ren ChangZhen, Hao LiSen. Signal transduction involved in activation of hepatic stellate cells[J]. Journal of Clinical Hepatology, 2015, 31(3): 452-456. doi: 10.3969/j.issn.1001-5256.2015.03.034 |
[13] | Zhang Zhan, Ping Jian, Xu LieMing. Screening Chinese medicine components for inhibition of human hepatic stellate cell migration[J]. Journal of Clinical Hepatology, 2012, 28(3): 183-188+191. |
[14] | Lu XiaoJu, Chen YongPing, Yang Tao, Cheng Yuan, Jin XiaoZhi, Shen ChunYan, Liu Jun, Wang ChunYing, Wang XiaoDong, Lin Zhuo. The influence of regulatory T cells in hepatic stellate cell proliferation and HA secretion[J]. Journal of Clinical Hepatology, 2012, 28(1): 39-43. |
[15] | Weng ShanGeng, Xu ChangGuo, Sun Ying, Shi Zheng, Lin LiJuan. Study on the apoptosis of rat hepatic stellate cells induced by kapamycin[J]. Journal of Clinical Hepatology, 2012, 28(3): 219-222. |
[16] | Yang Yang, Yang Liu, Fan HaiNing. Effect of H2S on intracellular Ca2+ concentration in HSCs under H2O2-induced oxidative stress conditions [J]. Journal of Clinical Hepatology, 2012, 28(11): 852-855. |
[17] | Zhang LiLi, Guo XiaoHong, Liu LiXin, Zhang QianQian. IGFBPrP1 siRNA induced apoptosis in rat hepatic stellate cells and its mechanism[J]. Journal of Clinical Hepatology, 2011, 27(9): 965-969+979. |
[18] | Dai YongMei, Cai LiMian, Lin Leng. The effect of octreotide on the expression of collagen、TIMP-1 and MMP-2 in HSC1[J]. Journal of Clinical Hepatology, 2008, 24(5): 332-334. |
[19] | Yang WeiFeng, Chen HouChang, Li Lin. Effect of Curcumin on proliferation and extracellular matrix secretion of rat hepatic stellate cells in vitro[J]. Journal of Clinical Hepatology, 2004, 20(3): 142-143. |
[20] | Cheng JiLin, Zhou Xin, Li DingGuo, Wei HongShan, Huang Xin, Wang ZhiRong, Zhan YuTao, Zhang Jing, Xu QinFang, Lu HanMing. RGDS peptides inhibit hepatic stellate cells synthesizing extracellular matrix stimulated by transforming growth factor beta.[J]. Journal of Clinical Hepatology, 2001, 17(3): 173-175. |